TY - CHAP
T1 - Cells for musculoskeletal tissue engineering
AU - Kong, K. Y.
AU - Lee, S.
AU - Zhou, C.
AU - Chen, M.
AU - Yang, G.
AU - He, L.
AU - Zhou, J.
AU - Zhou, Y.
AU - Jiang, N.
AU - Wang, C.
AU - Ricupero, C. L.
AU - Chen, D.
AU - Xing, H.
AU - Mao, J. J.
N1 - Funding Information:
We thank Ms. R. Birdie, Q. Guo, and J. Melendez for administrative and technical assistance. The effort for composition of this article is supported by NIH grants R01AR065023 and R01DE023112 to J.J. Mao.
Publisher Copyright:
© 2015 Elsevier Ltd. All rights reserved.
PY - 2015/4/23
Y1 - 2015/4/23
N2 - Central to the field of regenerative medicine and tissue engineering is the ability to manipulate stem/progenitor cells for the benefit of regeneration of tissues and organs. This chapter describes stem/progenitor cell types that have been utilized in the regeneration of musculoskeletal tissues. Pluripotent stem cells can produce all three germ layers, although their safe and reproducible differentiation into specific tissue lineages of mesoderm cells such as osteoblasts, tenocytes, or chondrocytes is not yet well delineated. Mesenchymal stem/progenitor cells (MSCs) from bone marrow, periosteum, adipose, and other sources have been used broadly not only for repair of musculoskeletal defects, but also other disease models such as diabetes, myocardial ischemia, stroke, and graft-versus-host disease. The behavior of stem/progenitor cells is governed by signaling cues including growth factors and transcriptional factors, and increasingly demonstrated by biomaterials that modulate cell-cell interactions and tissue oxygenation. In this chapter, we critically evaluate current literature on stem/progenitor cells and their regulatory cues in musculoskeletal tissue engineering.
AB - Central to the field of regenerative medicine and tissue engineering is the ability to manipulate stem/progenitor cells for the benefit of regeneration of tissues and organs. This chapter describes stem/progenitor cell types that have been utilized in the regeneration of musculoskeletal tissues. Pluripotent stem cells can produce all three germ layers, although their safe and reproducible differentiation into specific tissue lineages of mesoderm cells such as osteoblasts, tenocytes, or chondrocytes is not yet well delineated. Mesenchymal stem/progenitor cells (MSCs) from bone marrow, periosteum, adipose, and other sources have been used broadly not only for repair of musculoskeletal defects, but also other disease models such as diabetes, myocardial ischemia, stroke, and graft-versus-host disease. The behavior of stem/progenitor cells is governed by signaling cues including growth factors and transcriptional factors, and increasingly demonstrated by biomaterials that modulate cell-cell interactions and tissue oxygenation. In this chapter, we critically evaluate current literature on stem/progenitor cells and their regulatory cues in musculoskeletal tissue engineering.
KW - Embryonic stem cell (ESC)
KW - Endothelial progenitor cell (EPC)
KW - Human embryonic stem cell (HESC)
KW - Mesenchymal stem/progenitor cell (MSC)
KW - Perivascular stromal cells
UR - http://www.scopus.com/inward/record.url?scp=84940118643&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940118643&partnerID=8YFLogxK
U2 - 10.1016/B978-1-78242-301-0.00002-1
DO - 10.1016/B978-1-78242-301-0.00002-1
M3 - Chapter
AN - SCOPUS:84940118643
SN - 9781782423010
SP - 25
EP - 42
BT - Regenerative Engineering of Musculoskeletal Tissues and Interfaces
PB - Elsevier Inc.
ER -